Pharmacovigilance Milestones 6 months H1 2026

Six Months of Pharmacovigilance Excellence in 2026: Delivering Global Drug Safety with Quality and Compliance

• Post author:Dipesh Chodvadia
• Post published:July 9, 2026
• Post category:Blog/News/Pharmacovigilance

Pharmacovigilance Beyond Compliance Pharmacovigilance is no longer limited to meeting regulatory requirements. It has become a strategic function that enables sponsors to identify safety signals early, maintain global compliance, and…

Continue ReadingSix Months of Pharmacovigilance Excellence in 2026: Delivering Global Drug Safety with Quality and Compliance

Unannounced US-FDA inspection concludes with Zero 483 at Lambda's Ahmedabad Facility

Unannounced US FDA inspection concludes with Zero 483 at Lambda’s Ahmedabad Facility

• Post author:Dipesh Chodvadia
• Post published:May 2, 2026
• Post category:News

NEWS

Continue ReadingUnannounced US FDA inspection concludes with Zero 483 at Lambda’s Ahmedabad Facility

Lambda’s Clinical Laboratory, Ahmedabad - Consistently CAP accredited since 2005

CAP Accreditation Extended till 01 March 2028, Marking Continuous Compliance Since 2005

• Post author:Dipesh Chodvadia
• Post published:April 16, 2026
• Post category:News/Labs

NEWS

Continue ReadingCAP Accreditation Extended till 01 March 2028, Marking Continuous Compliance Since 2005

ANVISA Brazil - Successful Renewal - Ahmedabad Mehsana - Lambda CRO

ANVISA Accreditation renewed successfully for Lambda’s Ahmedabad and Mehsana Facilities

• Post author:Dipesh Chodvadia
• Post published:December 3, 2025
• Post category:News

NEWS

Continue ReadingANVISA Accreditation renewed successfully for Lambda’s Ahmedabad and Mehsana Facilities

Bioanalytical Excellence Upheld - Unannounced US FDA inspection concludes with Zero 483s - Lambda CRO

Bioanalytical Excellence Upheld – Unannounced US FDA inspection concludes with Zero 483s

• Post author:Dipesh Chodvadia
• Post published:July 19, 2025
• Post category:News

NEWS

Continue ReadingBioanalytical Excellence Upheld – Unannounced US FDA inspection concludes with Zero 483s

Lambda Clears 4 Back-to-Back US FDA PV Inspections in 12 Months Without 483s

Lambda Successfully Completes US FDA Pharmacovigilance Inspection with Zero 483s – 4th Consecutive in One Year

• Post author:Dipesh Chodvadia
• Post published:July 12, 2025
• Post category:News

NEWS

Continue ReadingLambda Successfully Completes US FDA Pharmacovigilance Inspection with Zero 483s – 4th Consecutive in One Year

US FDA Inspection Success - NO FORM 483 - Lambda CRO

Lambda Ahmedabad Successfully Completes USFDA Inspection without any 483 Observations

• Post author:Dipesh Chodvadia
• Post published:May 5, 2025
• Post category:News

NEWS

Continue ReadingLambda Ahmedabad Successfully Completes USFDA Inspection without any 483 Observations

USFDA ANDA Approval - Protein-bound Paclitaxel - Lambda Bioanalytical

USFDA Approves ANDA for Protein-Bound Paclitaxel Injection: Program supported by Lambda as the key Bioanalytical Partner

• Post author:Dipesh Chodvadia
• Post published:April 22, 2025
• Post category:News

NEWS

Continue ReadingUSFDA Approves ANDA for Protein-Bound Paclitaxel Injection: Program supported by Lambda as the key Bioanalytical Partner

EMA Excellence! - EMA Excellence Success!

Lambda Successfully Completes Multi-Site EMA Inspection for Biosimilar Product

• Post author:Dipesh Chodvadia
• Post published:March 6, 2025
• Post category:News

NEWS

Continue ReadingLambda Successfully Completes Multi-Site EMA Inspection for Biosimilar Product

Lambda Successfully Completes Swissmedic Inspection for Pharmacovigilance Services

Lambda Successfully Completes Swissmedic Inspection for Pharmacovigilance Services

• Post author:Dipesh Chodvadia
• Post published:March 1, 2025
• Post category:News

NEWS

Continue ReadingLambda Successfully Completes Swissmedic Inspection for Pharmacovigilance Services